GH Research (GHRS) Earnings Date & Reports

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

GHRS is expected to report earnings to rise 105.18% to -34 cents per share on May 14

Q1'25

Est.

$-0.35

Q4'24

Beat

by $0.05

Q3'24

Beat

by $0.01

Q2'24

Beat

by $0.02

Q1'24

Beat

by $0.08

The last earnings report on February 27 showed earnings per share of -17 cents, beating the estimate of -22 cents. With 207.49K shares outstanding, the current market capitalization sits at 612.84M.

View a ticker or compare two or three

Compare

GHRS